American Society for Clinical Pathology - Strict Adherence to a Blood Bank Specimen Labeling Policy by All Clinical Laboratories Significantly Reduces the Incidence of “Wrong Blood in Tube”

Strict Adherence to a Blood Bank Specimen Labeling Policy by All Clinical Laboratories Significantly Reduces the Incidence of “Wrong Blood in Tube”

Edward O’Neill, MD
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA

Leslie Richardson-Weber, MT(ASCP)
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA

Gina McCormack, MS, MT(ASCP)
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA

Lynne Uhl, MD
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA

Richard L. Haspel, MD, PhD
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA

Keywords: Mistransfusion; Specimen labeling; Wrong blood in tube

Upon completion of this activity, you will be able to:

describe the potential impact on patient care of reducing mistransfusion.
define the incidence of mistransfusion and how it compares to other transfusion risks.
list steps and procedures for proper specimen labeling to prevent mistransfusion.

This activity meets MOC Part II Lifelong Learning requirements. A self-assessment option is available for pathologists attending this program to earn SAM credits for Maintenance of Certification, Part II Self-Assessment Modules (MOC-SAM) for part of the course.

List Price

$20.00

Member Price

$15.00

From:
Email:
To:
Email:
Subject:
Message: